Ambu A/S (OTCMKTS:AMBBY) Stock Price Down 0.9% – Here’s Why

Ambu A/S (OTCMKTS:AMBBYGet Free Report) shares traded down 0.9% on Monday . The company traded as low as $18.28 and last traded at $18.28. 250 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 708 shares. The stock had previously closed at $18.45.

Ambu A/S Stock Performance

The firm has a market capitalization of $4.30 billion and a price-to-earnings ratio of 91.40. The company has a current ratio of 2.52, a quick ratio of 1.51 and a debt-to-equity ratio of 0.09. The stock’s 50-day moving average is $19.75 and its 200-day moving average is $18.90.

Ambu A/S (OTCMKTS:AMBBYGet Free Report) last posted its earnings results on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a net margin of 8.55% and a return on equity of 8.09%. The firm had revenue of $199.56 million for the quarter.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

See Also

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.